Literature DB >> 16216861

Left ventricular adaptation after atrial septal defect closure assessed by increased concentrations of N-terminal pro-brain natriuretic peptide and cardiac magnetic resonance imaging in adult patients.

M Weber1, T Dill, A Deetjen, T Neumann, O Ekinci, J Hansel, A Elsaesser, V Mitrovic, C Hamm.   

Abstract

OBJECTIVE: To determine in an observational study whether N-terminal pro-brain natriuretic peptide (NT-proBNP) is raised in patients with an atrial septal defect (ASD) and whether concentrations change after interventional closure.
METHODS: 12 patients (6 men, mean (SD) age 44.4 (18.6) years) with a moderate sized ASD type II (23.3 (4.5) mm, pulmonary to systemic flow ratio 2.1 (0.68)) were investigated. In all patients a magnetic resonance imaging (MRI) study was performed and NT-proBNP was assessed at baseline and early (9 (13) days) and late (138 (64) days) after intervention.
RESULTS: Concentrations of NT-proBNP were found to be within the normal range at baseline (median 87 pg/ml, interquartile range 65-181 pg/ml) but increased early after the interventional closure (315 pg/ml, 133-384 pg/ml, p = 0.005 versus baseline). The increase of NT-proBNP was associated with an increase in left ventricular dimensions as assessed by MRI (left ventricular end diastolic volume 104 (27) ml to 118 (27) ml, p = 0.003). Late after ASD closure NT-proBNP returned to baseline concentrations (102 pg/ml, 82-188 pg/ml, p = 0.004 versus early follow up).
CONCLUSION: These findings suggest the presence of transitory haemodynamic stress during adaptation of the left ventricle after ASD closure, which may contribute to the understanding of the pathological mechanism of acute heart failure and delayed improvement of exercise capacity after ASD closure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216861      PMCID: PMC1860932          DOI: 10.1136/hrt.2005.065607

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  30 in total

1.  Abnormalities of left ventricular function and geometry in adults with an atrial septal defect. Ventriculographic, hemodynamic and echocardiographic studies.

Authors:  K A Popio; R Gorlin; L E Teichholz; P F Cohn; D Bechtel; M V Herman
Journal:  Am J Cardiol       Date:  1975-09       Impact factor: 2.778

2.  Assessment of left ventricular function in secundum atrial septal defect by computer analysis of the M-mode echocardiogram.

Authors:  M G St John Sutton; A J Tajik; L A Mercier; J B Seward; E R Giuliani; E L Ritman
Journal:  Circulation       Date:  1979-11       Impact factor: 29.690

3.  Paradoxical and pseudoparadoxical interventricular septal motion in patients with right ventricular volume overload.

Authors:  M Feneley; T Gavaghan
Journal:  Circulation       Date:  1986-08       Impact factor: 29.690

Review 4.  Congenital heart disease in adults.

Authors:  A N Brest
Journal:  Cardiovasc Clin       Date:  1970

5.  Abnormal left heart function after operation for atrial septal defect.

Authors:  H Davies; G C Oliver; W J Rappoport; N Gazetopoulos
Journal:  Br Heart J       Date:  1970-11

6.  A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography.

Authors:  M A Quinones; A D Waggoner; L A Reduto; J G Nelson; J B Young; W L Winters; L G Ribeiro; R R Miller
Journal:  Circulation       Date:  1981-10       Impact factor: 29.690

7.  Atrial septal defect: acute left heart failure after surgical closure.

Authors:  J Beyer
Journal:  Ann Thorac Surg       Date:  1978-01       Impact factor: 4.330

8.  [Acute left heart failure following repair of atrial septal defects. Its treatment by reopening].

Authors:  J Beyer; L Brunner; W Hügel; E Kreuzer; B Reichart; L Sunder-Plassmann; W Klinner
Journal:  Thoraxchir Vask Chir       Date:  1975-08

9.  Normal left ventricular systolic function in adults with atrial septal defect and left heart failure.

Authors:  B A Carabello; A Gash; D Mayers; J F Spann
Journal:  Am J Cardiol       Date:  1982-06       Impact factor: 2.778

10.  Evidence of adverse ventricular interdependence in patients with atrial septal defects.

Authors:  Roxanne E Walker; Adrian M Moran; Kimberlee Gauvreau; Steven D Colan
Journal:  Am J Cardiol       Date:  2004-06-01       Impact factor: 2.778

View more
  7 in total

1.  NT-proBNP correlated with strain and strain rate imaging of the right ventricle before and after transcatheter closure of atrial septal defects.

Authors:  Raghda Ghonimy Elsheikh; Mohamed Hegab; Andras Szatmari
Journal:  J Saudi Heart Assoc       Date:  2012-10-13

2.  Impact of transcatheter closure of atrial septal defects on cardiac function.

Authors:  Hideki Tashiro; Kenji Suda; Yoshifumi Tananari; Shinichi Itou
Journal:  J Med Ultrason (2001)       Date:  2012-03-09       Impact factor: 1.314

3.  Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesia.

Authors:  R Maharaj
Journal:  J Saudi Heart Assoc       Date:  2012-02-01

4.  Rapid Left Ventricular Recovery After Correction of a Secundum Atrial Septal Defect: Understanding the Hemodynamics.

Authors:  Akanksha N Thakkar; Mahwash Kassi; C Huie Lin
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Jul-Sep

5.  Evolution of blood biomarker levels following percutaneous atrial septal defect closure in adults.

Authors:  Laurie W Geenen; Lucas Uchoa de Assis; Vivan J M Baggen; Jannet A Eindhoven; Judith A A E Cuypers; Eric Boersma; Jolien W Roos-Hesselink; Annemien E van den Bosch
Journal:  Int J Cardiol Heart Vasc       Date:  2020-07-21

6.  Percutaneous closure of atrial septal defects leads to normalisation of atrial and ventricular volumes.

Authors:  Karen S L Teo; Benjamin K Dundon; Payman Molaee; Kerry F Williams; Angelo Carbone; Michael A Brown; Matthew I Worthley; Patrick J Disney; Prashanthan Sanders; Stephen G Worthley
Journal:  J Cardiovasc Magn Reson       Date:  2008-12-01       Impact factor: 5.364

7.  The effects of super-flux (high performance) dialyzer on plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-Terminal proBNP in end-stage renal disease patients on dialysis.

Authors:  Yasuaki Nakagawa; Toshio Nishikimi; Koichiro Kuwahara; Shinji Yasuno; Hideyuki Kinoshita; Yoshihiro Kuwabara; Kazuhiro Nakao; Takeya Minami; Chinatsu Yamada; Kenji Ueshima; Yoshihiro Ikeda; Hiroyuki Okamoto; Kazukiyo Horii; Kiyoshi Nagata; Kenji Kangawa; Naoto Minamino; Kazuwa Nakao
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.